Tamar Thompson's most recent trade in Avidity Biosciences Inc was a trade of 22,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avidity Biosciences Inc | Tamar Thompson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 22,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 22,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 13,489 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 10,034 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Feb 2026 | 6,692 | 0 | - | - | Common Stock | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,413 | 3,773 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2025 | 1,413 | 119,663 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 18,115 | 116,555 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2025 | 5,468 | 122,023 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 947 | 121,076 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2025 | 947 | 2,360 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 10,034 | 10,034 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 6,692 | 6,692 | - | 0 | Common Stock | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1,413 | 1,413 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1,413 | 98,440 | - | - | Restricted Stock Units | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 23,248 | 97,012 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Nov 2024 | 2,841 | 99,853 | - | - | Restricted Stock Units | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 30,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.63 per share. | 07 Oct 2024 | 30,000 | 30,000 | - | 27.6 | 828,900 | Common Stock |
| Avidity Biosciences Inc | Tamar Thompson | Director | Sale of securities on an exchange or to another person at price $ 44.98 per share. | 07 Oct 2024 | 30,000 | 0 | - | 45.0 | 1,349,259 | Common Stock |
| Avidity Biosciences Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 13,489 | 13,490 | - | - | Stock Option (Right to Buy) | |
| Catalyst Pharma Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 29,524 | 69,524 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Thompson Tamar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 4,240 | 73,764 | - | - | Restricted Stock Units | |
| Avidity Biosciences Inc | Tamar Thompson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) |